HVAX Technologies IPO Key Dates, Price, GMP – HVAX Technologies’ initial public offering is scheduled to begin on September 27. HVAX Technologies’ SME IPO aims to raise ₹33.53 crores. The HVAX Technologies IPO price band is set at ₹435 to ₹458, with a market lot of 300 shares.
The price range for HVAX Technologies’ IPO is ₹435 to ₹458 per share. HNI is 15%, QIB is 50%, and the retail quota is 35%. On October 7, 2024, HVAX Technologies will go public and list on the NSE. October 3, 2024 is the date set aside for HVAX Technologies’ initial public offering. In 2023, the company’s revenue was ₹96.14 crore, while in 2041, it recorded ₹107.47 crores. In 2024, the company’s profit was ₹9.39 crores, compared to ₹5.20 crores in 2023. Investors in the IPO should apply for a lengthy term, according to the financials.
HVAX Technologies IPO Details (Date, Price, GMP)
| IPO Open Date | September 27, 2024 |
| IPO Close Date | October 1, 2024 |
| Listing Date | Monday, October 7, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹435 to ₹458 per share |
| Lot Size | 300 Shares |
| Total Issue Size | 732,000 shares
(aggregating up to ₹33.53 Cr) |
| Fresh Issue | 732,000 shares
(aggregating up to ₹33.53 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
HVAX Technologies Financials
HVAX Technologies Limited’s revenue increased by 12% and profit after tax (PAT) increased by 80% between the fiscal years ended March 31, 2024 and March 31, 2023.
| FY 2024 | |
| Assets | 6,366.32 |
| Revenue | 10,746.99 |
| Profit After Tax | 939.07 |
| Net Worth | 3,059.83 |
| ROE | 39.29% |
| ROCE | 25.17% |
| Debt/Equity | 0.8 |
| RoNW | 30.69% |
| P/BV | 3.06 |
| PAT Margin (%) | 8.85 |
About the Company – HVAX Technologies
Established in November 2010, HVAX Technologies Limited. The business started out as an HVAC contractor and now offers turnkey projects for the planning, obtaining, and construction of controlled environments and cleanroom infrastructure. It also offers equipment sales and supply in addition to design, build, and consulting services for pharmaceutical and healthcare companies.
Mainly pharmaceutical firms, but also chemical, hospital, healthcare, and fast-moving consumer goods corporations are among the clientele of the company. Together with design, engineering, and consultancy for pharmaceutical and healthcare firms, the company is involved in turnkey projects for the planning, acquiring, and construction of infrastructure for controlled environments and cleanrooms.
